Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion-Reference-Cited by-同舟云学术

Effects of PRIMA-1 on chronic lymphocytic leukaemia cells with and without hemizygous p53 deletion

Published:2004-10-11 Issue:3 Volume:127 Page:285-291
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Nahi H.,Lehmann S.,Mollgard L.,Bengtzen S.,Selivanova G.,Wiman K. G.,Paul C.,Merup M.

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.05210.x/fullpdf

Reference33 articles.

1. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients;Aas;Nature Medicine,1996

2. Chemosensitivity testing of human tumors using a microplate adenosine triphosphate luminescence assay: clinical correlation for cisplatin resistance of ovarian carcinoma;Andreotti;Cancer Research,1995

3. Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound;Bykov;Nature Medicine,2002a

4. Mutant p53-dependent growth suppression distinguishes PRIMA-1 from known anticancer drugs: a statistical analysis of information in the National Cancer Institute database;Bykov;Carcinogenesis,2002b

5. B-cell chronic lymphocytic leukemia: a bird of a different feather;Caligaris-Cappio;Journal of Clinical Oncology,1999

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting p53 pathways: mechanisms, structures, and advances in therapy;Signal Transduction and Targeted Therapy;2023-03-01

2. Richter Syndrome: From Molecular Pathogenesis to Druggable Targets;Cancers;2022-09-24

3. Targeting the p53 Pathway in CLL: State of the Art and Future Perspectives;Cancers;2021-09-18

4. Antitumor Effects of PRIMA-1 and PRIMA-1Met (APR246) in Hematological Malignancies: Still a Mutant P53-Dependent Affair?;Cells;2021-01-07

5. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia;Haematologica;2021-01-07